Latest news with #BiographTrinion
Yahoo
23-06-2025
- Health
- Yahoo
Siemens Healthineers forms theranostics research collaboration with MGH
Siemens Healthineers has struck a research partnership with Massachusetts General Hospital (MGH) in the US to establish a Therapy Command Center. This centre is designed to implement theranostics across the hospital and its facilities in Massachusetts, Maine, and New Hampshire. It will facilitate data collection, provide real-time monitoring, and support healthcare professionals in making informed patient care decisions. Theranostics combines molecular imaging techniques to assess disease progression and evaluate treatment efficacy. MGH nuclear medicine and molecular imaging chief Umar Mahmood said: 'The Therapy Command Centre helps provide a framework that will enable the integration of a wide variety of patient imaging and laboratory data, combined with population-based data for enhanced individual patient outcomes. 'This collaboration will help expand theranostics across the region, advancing personalised medicine through precision diagnoses and tailored therapies.' Researchers from Siemens Healthineers and MGH will use advanced imaging technology, including the Biograph Vision Quadra and Biograph Trinion positron emission tomography/computed tomography (PET/CT) scanners. Their research aims to understand the effects of radiation on molecular and biological processes, as well as assess toxicity levels in both cancerous and healthy tissues of patients undergoing radiopharmaceutical therapy. This knowledge is crucial for advancing personalised medicine, according to the company. Siemens Healthineers Molecular Imaging James Williams said: 'This research collaboration, which is based on a relationship between Siemens Healthineers and Massachusetts General Hospital that spans more than 20 years, will enable innovations along the patient's clinical pathway, provide precision diagnoses, and deliver highly effective forms of customised therapy.' In July 2024, Redhill Cancer Hospital, part of RVL Healthcare, signed a memorandum of understanding (MoU) with Siemens Healthineers to create a Cancer Centre and Research Park in Nairobi, Kenya. "Siemens Healthineers forms theranostics research collaboration with MGH" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
23-06-2025
- Health
- Yahoo
MGH and Siemens Healthineers to establish Therapy Command Center
Massachusetts General Hospital (MGH) in the US has formed a research partnership with Siemens Healthineers to establish a Therapy Command Center. This centre is designed to implement theranostics across the hospital and its facilities in Massachusetts, Maine, and New Hampshire. It will facilitate data collection, provide real-time monitoring, and support healthcare professionals in making informed patient care decisions. Theranostics combines molecular imaging techniques to assess disease progression and evaluate treatment efficacy. MGH nuclear medicine and molecular imaging chief Umar Mahmood said: 'The Therapy Command Centre helps provide a framework that will enable the integration of a wide variety of patient imaging and laboratory data, combined with population-based data for enhanced individual patient outcomes. 'This collaboration will help expand theranostics across the region, advancing personalised medicine through precision diagnoses and tailored therapies.' Researchers from Siemens Healthineers and MGH will use advanced imaging technology, including the Biograph Vision Quadra and Biograph Trinion positron emission tomography/computed tomography (PET/CT) scanners. Their research aims to understand the effects of radiation on molecular and biological processes, as well as assess toxicity levels in both cancerous and healthy tissues of patients undergoing radiopharmaceutical therapy. This knowledge is crucial for advancing personalised medicine, according to the company. Siemens Healthineers Molecular Imaging James Williams said: 'This research collaboration, which is based on a relationship between Siemens Healthineers and Massachusetts General Hospital that spans more than 20 years, will enable innovations along the patient's clinical pathway, provide precision diagnoses, and deliver highly effective forms of customised therapy.' In July 2024, Redhill Cancer Hospital, part of RVL Healthcare, signed a memorandum of understanding (MoU) with Siemens Healthineers to create a Cancer Centre and Research Park in Nairobi, Kenya. "MGH and Siemens Healthineers to establish Therapy Command Center" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
09-05-2025
- Health
- Yahoo
Pella Regional, Knoxville Hospital break ground on cancer treatment facility
PELLA — Pella Regional Medical Center and Knoxville Hospital and Clinics broke ground on a project to bring improved cancer treatment to Marion County. Members of the hospitals and community celebrated the beginning of construction on the new South Central Iowa Radiation Center at the Pella Regional campus Thursday. According to Pella Regional CEO Bob Kroese, the project came as a collaboration built on a mutual need for patients in both communities, and in Marion County as a whole. "It's kind of a first of its kind," Kroese said. "But when we both realized — both of our organizations realized — there was something we wanted to do desperately for our communities is to bring the radiation therapy to our community, and we both found out we were interested in doing it, we decided to talk it over with each other and decided … maybe if we do one united front, it will serve that large patient population even more effectively and really reduce the travel times for people that need that care." The 7,800-square-foot facility is budgeted at $14 million, and is expected to include diagnostic tools and treatment technologies like a TrueBeam linear accelerator to deliver radiation treatments and a combined Biograph Trinion PET/CT unit for diagnosing cancer and determining course of treatment. Iowa has the second highest cancer rates in the United States and a according to Kroese, the new center will play a major role in fighting the issue locally. "It's very, very unfortunate that our cancer incidences are as high as they are, but it's up to us professionally through our missions to be able to provide very, very, high quality … of care, but also do whatever we can to reduce the burden of travel," Kroese said. "If we do that, we're fulfilling our mission and providing a great service for this area." Knoxville Hospital and Clinics CEO Kevin Kincaid reflected this when speaking at the groundbreaking, stressing the importance of nearby care and reduced travel. "And we all know that when you're able to deliver care — especially around cancer — locally, what we're giving people back is the biggest gift at all when you're talking about cancer, and that's time," he said. "So that's what we're interested in, and that's what we're going to do." The new radiation and oncology center is expected to be opened in 2027.
